Business

January 6, 2014 11:05 AM

Oxygen Bio's stock surges after company releases clinical trial details

Oxygen Biotherapeutics stock jumped 16 percent Monday after the Morrisville company announced details of late-stage clinical trials for its cardiovascular drug.

Related content

Comments